Janusz Kłoczko Selected Research

Janusz Kłoczko Research Topics

Disease

5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2017 - 02/2008
3	Multiple Myeloma 03/2021 - 10/2002
3	Neoplasms (Cancer) 12/2015 - 10/2002
2	Leukemia 01/2014 - 02/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Monoclonal Gammopathy of Undetermined Significance 03/2021
1	Disease Progression 05/2018
1	monosomy Chromosome 7 10/2017
1	Down Syndrome (Down's Syndrome) 10/2017
1	Hemorrhage 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Residual Neoplasm 01/2008
1	Atrophy 11/2004
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2002
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2002
1	Cholecystolithiasis 08/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2002

Drug/Important Bio-Agent (IBA)

3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2017
2	Bortezomib (Velcade)FDA Link 03/2021 - 12/2015
2	Proteasome InhibitorsIBA 03/2021 - 12/2015
2	ofatumumab FDA Link 01/2020 - 01/2017
2	Complement C2 (Complement Component 2)IBA 01/2020 - 01/2017
2	fludarabineIBA 01/2020 - 01/2017
2	Cladribine FDA LinkGeneric 05/2018 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2008
1	ponatinibIBA 01/2022
1	Inosine Monophosphate (IMP)IBA 03/2021
1	carfilzomibIBA 03/2021
1	Rituximab (Mabthera)FDA Link 05/2018
1	Imatinib Mesylate (Gleevec)FDA Link 10/2017
1	Interferon-alpha (Interferon Alfa)IBA 10/2017
1	Carbapenems (Carbapenem Antibiotics)IBA 08/2017
1	Interleukin-2 Receptor alpha SubunitIBA 02/2016
1	AntibodiesIBA 01/2016
1	Death Domain ReceptorsIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	LigandsIBA 01/2014
1	AntigensIBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2008
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2008
1	Reticulin (Reticular Fiber)IBA 11/2004
1	CollagenIBA 11/2004
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2002
1	Thromboplastin (Tissue Factor)IBA 10/2002
1	Thrombin FDA Link 08/2002
1	Protein CIBA 08/2002
1	Antithrombin IIIIBA 08/2002
1	plasmin-plasmin inhibitor complexIBA 03/2002
1	Fibrinolysin FDA Link 03/2002
1	antithrombin III-protease complexIBA 03/2002
1	fibrin fragment D (D-dimer)IBA 03/2002
1	Prothrombin (Factor II)IBA 03/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2015
1	Induction Chemotherapy 02/2016
1	Minor Surgical Procedures (Minor Surgery) 01/2016
1	Aftercare (After-Treatment) 01/2008
1	Laparoscopic Cholecystectomy 08/2002